P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date
Decision
P/0162/2022 : EMA decision of 13 May 2022 on the agreement of a paediatric investigation plan and on the granting of a deferral for virus-like particle of SARS-CoV-2 spike protein (recombinant, adjuvant) (CoVLP) (EMEA-003008-PIP01-21)
Virus-like particle of SARS-CoV-2 spike protein (recombinant, adjuvanted) (CoVLP) - Notification of discontinuation of a paediatric development which is covered by an agreed PIP Decision